SI-Bone inc participated in the NASS 2014 annual convention of spine surgeons at the Moscone Convention Center from Nov 12-14. SI-Bone located in San Jose California is a privately held company that has created a significant market niche in treating severe sacro-iliac bone pain with it’s iFuse™ system.
I had the great pleasure of speaking with Jeff Dunn, CEO of SI-Bone and a short interview at the bottom of this article. Mr. Dunn has over thirty years of executive experience, including serving as the CEO of six companies prior to founding and serving as the CEO and President of SI-BONE. His medical device experience includes sacroiliac surgery, ankle replacement, and small bone extremity fusion. Mr. Dunn has taken one company public, sold all the others to larger public companies, started numerous companies, served on numerous boards of directors and is an advisor to other CEOs.
Confusing Diagnosis – Low Back Pain May be Sacro-Iliac Bone Pain
Up to 25% of all low back pain sufferers is caused by Sacro-iliac bone pain and may be confused as lumbo-sacral in origin. These patients may receive a lumb0-sacral spine fusion when they really needed a sacro-iliac bone fusion. The incidence of sacro-iliac joint degeneration in post-lumbar fusion surgery is 75% at 5 years post-surgery. The iFuse implant system is a minimally invasive surgical procedure that can be done in a hospital setting in about 1 hour. Three titanium triangular implants are placed into the sacro-iliac joint improving stability of the joint. According to Mr Dunn, “clinical studies show that many of our patients exhibit a decrease in pain post-operatively“. As you can see in the graph below, the relief of pain is very rapid.
Interview with Jeff Dunn, CEO of SI-Bone, he discusses the company and the iFuse implant system.
